insights_auto
Why is ARGNF down 15,58%?
Dive Deeperchevron_right
ARGNF:OTCMKTS
argenx SE
USD 790,15
arrow_downward
-15,58%(-145,85) 1D
13 Okt., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGNF...
Open
USD 790,15
High
USD 790,15
Low
USD 790,15
Mkt. cap
51,50 mjd
Avg. vol.
14,00
Volume
30,00
52-wk high
USD 1 020,00
52-wk low
USD 708,72
Beta
0,46
Shares outstanding
62,89 m
No. of employees
2 k
Open
USD 790,15
High
USD 790,15
Low
USD 790,15
Mkt. cap
51,50 mjd
Avg. vol.
14,00
Volume
30,00
52-wk high
USD 1 020,00
52-wk low
USD 708,72
Beta
0,46
Shares outstanding
62,89 m
No. of employees
2 k
News stories
From web sources and news partners
Simply Wall Street
·
8 minute gelede
Halozyme Stock Has The Bull Case Changed After Argenx Deal Expansion?
ad-hoc-news.de
·
11 uur gelede
Oppenheimer cuts target to USD 1,038 for Argenx stock
ad-hoc-news.de
·
14 uur gelede
Argenx stock pre-market at EUR 718.20
ad-hoc-news.de
·
1 dag gelede
Baird cuts target for Argenx stock to USD 823.00
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE